Panacea Biotec up 5 percent as it raises supply of life saving drug
New Delhi : Shares of Panacea Biotec surged 5 per cent after the company said it has increased availability of life saving drug Cilamin 250 capsules in India for treatment of Wilson's disease a genetic disorder in which copper builds up in the body.
The stock jumped 4.99 per cent to end at Rs 124.25 on BSE. Intra-day, it surged 8.15 per cent to Rs 128.
At NSE, shares of the company rose by 4.42 per cent to close at Rs 123.95."Panacea Biotec ensures increased availability of life saving drug Cilamin 250 (D-Penicillamine IP 250mg) capsules for treatment of Wilson's disease in India," the company said in a BSE filing.
It further said: "Cilamin250...Wtinessed short supply in the market in the last few months due to non-availability of raw materials D-Penicillamine in India. We have now improved supply of Cilamin250 capsules which has been made available in the retail market.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd